| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.082 | 0.08 |